GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice-Reference-Cited by-同舟云学术

GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice

Published:2019-06 Issue: Volume:151 Page:55-63
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Décarie-Spain Léa,Fisette Alexandre,Zhu Zhimeng,Yang Bin,DiMarchi Richard D.,Tschöp Matthias H.,Finan Brian,Fulton Stephanie,Clemmensen Christoffer^ORCID

Funder

Lundbeck Foundation (Fellowship

Novo Nordisk Foundation

FRQS

Canadian Institutes of Health Research

Postdoctoral Fellowship

FRSQ doctoral fellowship

Alexander von Humboldt Foundation

Helmholtz Alliance ICEMED

Helmholtz Initiative on Personalized Medicine iMed by Helmholtz Association

Initiative and Networking Fund of the Helmholtz Association

European Research Council ERC

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference58 articles.

1. Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons;Adams;Diabetes,2018

2. Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed;Alhadeff;Neuropsychopharmacology,2014

3. Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding;Alhadeff;Am. J. Physiol. Regul. Integr. Comp. Physiol.,2014

4. Endogenous glucagon-like peptide-1 receptor signaling in the nucleus tractus solitarius is required for food intake control;Alhadeff;Neuropsychopharmacology,2017

5. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake;Alhadeff;Endocrinology,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes;Diabetes Therapy;2024-04-04

2. Glucagon-Like Peptide 1: An Introduction and Possible Implications for Neuropsychiatry;The Journal of Neuropsychiatry and Clinical Neurosciences;2024-04

3. Unlocking Therapeutic Synergy: Tailoring Drugs for Comorbidities such as Depression and Diabetes through Identical Molecular Targets in Different Cell Types;Cells;2023-12-04

4. Elucidating the central anorexigenic mechanism of glucagon-like peptide 1 in Japanese quail (Coturnix japonica);General and Comparative Endocrinology;2023-08

5. GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity;Cell Reports;2023-05